use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use, according to a ...

In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable ...

In their paper, titled “Metformin-regulated glucose flux from the circulation to the intestinal lumen,” the investigators concluded, “A previously unrecognized, substantial flux of glucose ...

Metformin is a trusted treatment for type 2 diabetes, but some people are being prescribed the drug for weight loss. (Getty Images) ...